InVivo Biosystems
PrivateLast Round
VC Round
Jan 3, 2024
Total Funding Raised
$8.59M
Company Overview
InVivo Biosystems is a biotechnology company that provides a genome editing platform and preclinical services using C. elegans and zebrafish models to accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InVivo Biosystems Comparables
Compare InVivo Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZeClinics | 84% | |
| Magnitude Biosciences | 82% | |
| Cyagen Biosciences | 81% |
InVivo Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 3, 2024 | ||||
| Grant | Dec 7, 2023 | ||||
| Grant | Apr 24, 2020 | ||||
| Series A | Jul 29, 2019 | ||||
| Grant | Jan 28, 2014 |
Key People
Founding team and executive leadership
InVivo Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oregon Venture Fund | Series A |
| NIH RADx | Grant |
| ONAMI | VC Round |
| Portland Seed Fund | VC Round |
| Rogue Venture Partners | Series A, VC Round |
| Oregon Nanoscience and Microtechnologies Institute | Grant |
| Launch Oregon | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors increased 45% MoM.
- May 1, 2025
Monthly visitors increased 91% MoM, reaching 8.8K.
InVivo Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about InVivo Biosystems's valuation, stock price, and market status.
Is InVivo Biosystems a public or private company?
InVivo Biosystems is a private company.
What is the current stock price of InVivo Biosystems?
InVivo Biosystems is a private company with no public stock price. No recent secondary market data is available.
How much is InVivo Biosystems worth (valuation)?
Valuation information for InVivo Biosystems is not publicly available.
Can I buy InVivo Biosystems stock?
InVivo Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was InVivo Biosystems's last funding round?
InVivo Biosystems's most recent funding round was VC Round on January 3, 2024.
Who are the main investors in InVivo Biosystems?
Key investors in InVivo Biosystems include Oregon Venture Fund, Rogue Venture Partners.
Will InVivo Biosystems IPO soon?
No public IPO plans have been announced for InVivo Biosystems.
How can I track InVivo Biosystems secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InVivo Biosystems's secondary market activity and sign up for updates.